Skip to Content
Merck
  • The effect of transversus abdominis plane blocks on postoperative pain in laparoscopic colorectal surgery: a prospective, randomized, double-blind trial.

The effect of transversus abdominis plane blocks on postoperative pain in laparoscopic colorectal surgery: a prospective, randomized, double-blind trial.

Diseases of the colon and rectum (2014-10-07)
Deborah S Keller, Bridget O Ermlich, Nicholas Schiltz, Bradley J Champagne, Harry L Reynolds, Sharon L Stein, Conor P Delaney
ABSTRACT

Superior early pain control has been suggested with transversus abdominis plane blocks, but evidence-based recommendations for transversus abdominis plane blocks and their effects on patient outcomes are lacking. The aim of this study was to determine whether transversus abdominis plane blocks improve early postoperative outcomes in patients undergoing laparoscopic colorectal resection already on an optimized enhanced recovery pathway. This study is based on a prospective, randomized, double-blind controlled trial. The trial was conducted at a tertiary referral center. Patients undergoing elective laparoscopic colorectal resection were selected. Patients were randomly assigned to receive either a transversus abdominis plane block or a placebo placed intraoperatively under laparoscopic guidance. All followed a standardized enhanced recovery pathway. Patient demographics, perioperative procedures, and postoperative outcomes were collected. Postoperative pain and nausea/vomiting scores in the postanesthesia care unit and department, opioid use, length of stay, and 30-day readmission rates were measured. The trial randomly assigned 41 patients to the transversus abdominis plane block group and 38 patients to the control group. Demographic, clinical, and procedural data were not significantly different. In the postanesthesia care unit, the transversus abdominis plane block group had significantly lower pain scores (p < 0.01) and used fewer opioids (p < 0.01) than the control group; postoperative nausea/vomiting scores were comparable (p = 0.99). The transversus abdominis plane group had significantly lower pain scores on postoperative day 1 (p = 0.04) and throughout the study period (p < 0.01). There was no significant difference between groups in postoperative opioid use (p = 0.65) or nausea/vomiting (p = 0.79). The length of stay (median, 2 days experimental, 3 days control; p = 0.50) and readmission rate (7% experimental, 5% control, p = 0.99) was similar across cohorts. This study was conducted a single center. Transversus abdominis plane blocks improved immediate short-term opioid use and pain outcomes. Pain improvement was durable throughout the hospital stay. However, the blocks did not translate into less overall narcotic use, shorter length of stay, or lower readmission rates.

MATERIALS
Product Number
Brand
Product Description

Supelco
Diclofenac sodium salt, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Diclofenac sodium salt, analytical standard
Diclofenac for system suitability, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Diclofenac sodium salt
Supelco
Bupivacaine hydrochloride monohydrate, analytical standard, for drug analysis
Supelco
Bupivacaine hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material
Diclofenac sodium, European Pharmacopoeia (EP) Reference Standard
USP
Diclofenac sodium, United States Pharmacopeia (USP) Reference Standard
Bupivacaine hydrochloride, European Pharmacopoeia (EP) Reference Standard
USP
Bupivacaine hydrochloride, United States Pharmacopeia (USP) Reference Standard